Sort
39,280 grants matching “leukemia”
Genomics of myelodysplastic syndromes
$535,500Washington University · R01 · FY2005 · HL
Genomics of Acute Myelogenous Leukemia (AML): Relapse and Resistance Factors
$535,495John F Dipersio · Washington University · P01 · FY2011 · CA
Role of the TET1 short isoform in MDS development and maintenance
$535,489Zhijian Qian · University Of Florida · R01 · FY2025 · HL
Role of the TET1 short isoform in MDS development and maintenance
$535,489Zhijian Qian · University Of Florida · R01 · FY2023 · HL
Role of the TET1 short isoform in MDS development and maintenance
$535,489Zhijian Qian · University Of Florida · R01 · FY2022 · HL
Transduction of Schistosoma mansoni by pseudotyped retrovirus
$535,489Paul J Brindley · George Washington University · R01 · FY2011 · AI
STAG2 mutations and 3D genome organization in glioblastoma multiforme
$535,445Todd A Waldman · Georgetown University · R01 · FY2025 · CA
Determining the Role and Targeting potential of Serine Metabolism in aggressive sub-types of Acute Myeloid Leukemia
$535,370Stephen Matthew Sykes · Washington University · R01 · FY2024 · CA
Validating Molecular Signature Risk Models of NSCLC
$535,358David H Harpole · Duke University · R01 · FY2007 · CA
COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children
$535,339Soheil Meshinchi · Public Health Institute · UG1 · FY2023 · CA
EZH2 in cancer biology and novel inhibitors
$535,301Jun Qi · Dana-Farber Cancer Inst · R01 · FY2020 · CA
A longitudinal assessment of frailty in young adult survivors of childhood cancer
$535,247Kirsten Kimberlie Ness · St. Jude Children'S Research Hospital · R01 · FY2015 · CA
A longitudinal assessment of frailty in young adult survivors of childhood cancer
$535,247Kirsten Kimberlie Ness · St. Jude Children'S Research Hospital · R01 · FY2016 · CA
Project 2: Defining the role of megakaryocyte abnormalities in the progression of primary myelofibrosis
$535,067Anna R Migliaccio · Icahn School Of Medicine At Mount Sinai · P01 · FY2022 · CA
RNA Polymerase II as a Therapeutic Target in Acute Myeloid Leukemia (AML) with RAS Signaling Activation
$534,924Catherine Choy Smith · University Of California, San Francisco · R01 · FY2023 · CA
Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
$534,854Laura Maria Calvi · University Of Rochester · R01 · FY2022 · AG
Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
$534,854Laura Maria Calvi · University Of Rochester · R01 · FY2023 · AG
Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
$534,854Laura Maria Calvi · University Of Rochester · R01 · FY2024 · AG
OCG Data Coordinating Center
$534,849Leonard Freedmand · Leidos Biomedical Research, Inc. · N01 · FY2019 · CA
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
$534,838Margaret Goodell · Baylor College Of Medicine · R01 · FY2014 · CA
Pathology Resource Network
$534,814Carl D Morrison · Roswell Park Cancer Institute Corp · P30 · FY2009 · CA
Tumor Microenvironment in Cancer Progression
$534,706Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Virally-induced tumorigenesis controlled by the microbiota
$534,676Tatyana V. Golovkina · University Of Chicago · R01 · FY2025 · CA
Protein-coding and non-coding RNA biomarkers for early detection of CLL
$534,545George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Targeting Novel Pathways in JMML
$534,541Reuben Kapur · Indiana University Indianapolis · R01 · FY2020 · HL